CRYSTALLINE (R) - (E) -2- (4- (2- (5- (1- (3, 5 -DICHLOROPYRIDIN-4 -YL) ETHOXY) - 1H - INDAZOL - 3 - YL) VINYL) -1 H- PYRAZOL- 1 -YL) ETHANOL AND ITS USE AS FGFR INHIBITOR
- 专利权人:
- ELI LILLY AND COMPANY
- 发明人:
- DISEROAD, BENJAMIN ALAN
- 申请号：
- SG2013013743
- 公开号：
- SG188286A1
- 申请日:
- 2011.09.29
- 申请国别(地区):
- SG
- 年份:
- 2013
- 代理人:
- 摘要：
- The present invention provides crystalline (R) - (E) -2- (4- (2- (5- (1- (3,5-dichloropyridin-4- yl) ethoxy) - 1H- indazol- 3 -yl) vinyl) - IH-pyrazol - 1 -yl) ethanol useful in the treatment of cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Crystalline (R) - (E) -2- (4- (2- (5- (1- (3, 5 -dichloropyridin-4 -yl) ethoxy) - 1H - indazol - 3 - yl) vinyl) -1 H- pyrazol- 1 -yl) ethanol and its use as FGFR inhibitor
- CRYSTALLINE (R) - (E) -2- (4- (2- (5- (1- (3, 5 -DICHLOROPYRIDIN-4 -YL) ETHOXY) - 1H - INDAZOL - 3 - YL) VINYL) -1 H- PYRAZOL- 1 -YL) ETHANOL AND ITS USE AS FGFR INHIBITOR
- COMPOSITION PHARMACEUTIQUE COMPRENANT UN INHIBITEUR SELECTIF DE LA TYROSINE KINASE FGFR
- ANNEALING PROCESS FOR A BIOABSORBABLE STENT
- COMPOSITION BASED ON BLOOD COMPOSITION ENRICHED WITH THROMBOCYTES AND/OR GROWTH FACTORS AND CONTAINS GEL-LIKE PROTEINS, AND METHOD FOR PRODUCTION THEREOF
